<i>Actinomyces meyeri</i>Empyema: A Case Report and Review of the Literature

Jung, Hae Won; Cho, Chong Rae; Ryoo, Ji Yoon; Lee, Hyun Kyo; Ha, So Young; Choi, Ji Hoon; Kwak, Yee Gyung

doi:10.1155/2015/291838

Cited by 17 publications

(27 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A. species can migrate into deeper structures and cause infection. 6 In most cases, chronic cervicofascial infection also known as “lumpy jaw” is the result and A. israelii is detected. 7 There are few data about the frequency of actinomycosis.…”

Section: Discussionmentioning

confidence: 99%

Actinomyces Meyeri Empyema Necessitatis—A Case Report and Review of the Literature

Ellebrecht

Pross

Schierholz

et al. 2019

Surg J

View full text Add to dashboard Cite

Pleural empyema necessitatis caused by Actinomyces meyeri is a rare but severe infection. A. species predominantly A. meyeri and A. israelii represent the second most common pathogen for empyema necessitans after mycobacteria. The incidence is reported in the literature to be 1:300,000. Men are thrice more likely to be affected than women. Pathogenetically, an infection can be triggered by aspiration in immunocompromised individuals which leads to an atelectasis with pneumonitis.In two cases, a 38-year-old construction worker and a 61-year-old woman with ulcerative breast carcinoma, who presented to the local emergency department with a painful swelling of the left chest, diagnostic workup revealed a pleural empyema necessitatis of the left chest. An antibiotic treatment was initiated with piperacillin/tazobactam and sulbactam/ampicillin, respectively. Temporally vacuum-dressing therapy was initiated after surgical debridement. In the course of the procedure, a reconstruction of tissue damage was feasible. The patients were recovered completely and discharged with an oral antibiotic treatment (amoxicillin) for 6 and 12 months, respectively.Thoracic actinomycosis is a relatively uncommon and traditionally chronic, indolent infection secondary to pulmonary infection with A. species. Surgical treatment is generally reserved for cases failing to resolve with antibiotic therapy. Early diagnosis, prompt debridement, and narrow spectrum β-lactam antibiotics can result in complete resolution of infection and good prognosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Actinomyces Meyeri Empyema Necessitatis—A Case Report and Review of the Literature

Ellebrecht

Pross

Schierholz

et al. 2019

Surg J

View full text Add to dashboard Cite

show abstract

“…A review of the English-language literature revealed only one case of A. meyeri empyema in a male with no history of medical illness. This patient was treated with a short-term of intravenous penicillin and oral amoxicillin and only a chest tube drainage, with no evidence of dissemination or recurrence [7] .…”

Section: Discussionmentioning

confidence: 99%

A rare case of Actinomyces meyeri empyema: Still a challenging entity to manage

Clérigo

Fernandes

Feliciano

et al. 2017

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

Actinomyces meyeri is a rare pathogen and an infrequent cause of human actinomycosis. Less than ten cases were reported in the English-literature to date concerning A. meyeri empyema. We herein report a case to promote the awareness and adequate management of the disease.A 44-year-old immunocompetent male with known pulmonary disease was diagnosed with an A. meyeri empyema. He underwent chest tube drainage and a short-term treatment with clindamycin for 4 months.This is the first report of a patient with structural pulmonary disease with an A. meyeri empyema treated with 4-month of clindamycin and chest tube drainage. In comparison to previous reports, our case was diagnosed early, empyema was effectively drained with one chest tube and symptoms and radiological findings were rapidly improved. Short-term antibiotic treatment can be well succeeded if an early diagnosis is made, there is no evidence of dissemination and adequate management is promptly instituted.

show abstract

“…Conventional therapy for actinomycosis is high-dose intravenous penicillin at a dose of 18–24 million units for 2–6 weeks, followed by oral therapy with amoxicillin or penicillin V for 6–12 months [5]. In penicillin allergic patients, such as in the case we presented here, tetracyclines are a good alternative, while erythromycin can be used in pregnant, penicillin-sensitive women [1].…”

Section: Discussionmentioning

confidence: 99%

“…A review of English-language literature revealed only 6 case reports of confirmed Actinomyces meyeri empyema [4, 5, 9–12]. Five of the six patients described were males.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Empyema Secondary toActinomyces meyeriTreated Successfully with Ceftriaxone Followed by Doxycycline

Paris

Piscopo

Cassar

2016

Case Reports in Infectious Diseases

View full text Add to dashboard Cite

Actinomycosis is a relatively rare infection caused by Gram-positive bacteria. We present the case of a 54-year-old, previously healthy, male patient with a history of severe penicillin allergy who developed severe pneumonia and empyema caused by Actinomyces meyeri. Presenting symptoms included productive cough, right upper quadrant pain, and chills and rigors. He required drainage of the empyema via tube and prolonged antibiotic treatment with intravenous ceftriaxone for 2 weeks followed by oral doxycycline for 6 months.

show abstract

Actinomyces meyeriEmpyema: A Case Report and Review of the Literature

Cited by 17 publications

References 14 publications

Actinomyces Meyeri Empyema Necessitatis—A Case Report and Review of the Literature

Actinomyces Meyeri Empyema Necessitatis—A Case Report and Review of the Literature

A rare case of Actinomyces meyeri empyema: Still a challenging entity to manage

Empyema Secondary toActinomyces meyeriTreated Successfully with Ceftriaxone Followed by Doxycycline

Contact Info

Product

Resources

About